The Impact of the Foreign Corrupt Practices Act on Corporate Boards
  • By Michael Marquardt

Read More →


The Lasting, Positive Impact of Sarbanes-Oxley
  • By Michael W. Peregrine

Read More →


Dodd-Frank and Corporate Governance
  • By John Mark Zeberkiewicz and Robert B. Greco

Read More →


Chair and CEO: To Split or not to Split?
  • By Beth Braverman

Read More →


The FCPA-SOX-Dodd-Frank Trifecta
  • By April Hall

Read More →


What He Taught: An Homage to Jim Kristie
  • By Alexandra Reed Lajoux

Read More →


Private Boards’ “Inflection” Moment
  • By Abby Adlerman

Read More →


Revaluing Assets and Liabilities When Paying Dividends or Repurchasing Shares
  • By Doug Raymond and Todd Schlitz

Read More →


Strategic Planning: How to Create Alignment Between the Board and Management Team
  • By Michael Mendes

Read More →


Upheaval: Healthcare Boards Embrace Pandemic-Driven Change
  • By Jena Abernathy

Read More →